Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy-Induced Cytokine Release Syndrome.
Soichiro MinamiYosuke KawashimaYasuhiko MunakataMasahiro MatsunoShuichiro HaraYusuke YamazakiTsuyoshi DomanShin SaitoTetsuo OdakaTakahiro OgasawaraHisashi ShimizuJun SugisakaTomoiki AibaYukihiro ToiShinsuke YamandaYuichiro KimuraShunichi SugawaraPublished in: Cancer reports (Hoboken, N.J.) (2024)
This indicates the potential effectiveness of early tocilizumab administration for ICI-induced CRS, even in mild cases.